Figure 1.
The conceptual framework of operating room bundle of care in the prevention of surgical site infection.
Figure 2.
Research framework.
Table 1.
Patients wound status based on BWAT in the control group.
| BWAT score | Day 1 Hemostasis phase | Day 2 Inflammatory phase | Day 3 Proliferative phase | |||
|---|---|---|---|---|---|---|
| F | % | F | % | F | % | |
| 18.0 | 1 | 3.3 | ||||
| 19.0 | 9 | 30.0 | ||||
| 20.0 | 14 | 46.7 | ||||
| 21.0 | 1 | 3.3 | 6 | 20.0 | ||
| 21.5 | 1 | 3.3 | ||||
| 22.0 | 4 | 13.3 | ||||
| 22.5 | 1 | 3.3 | ||||
| 23.0 | 5 | 16.7 | ||||
| 23.5 | 2 | 6.7 | ||||
| 24.0 | 7 | 23.3 | ||||
| 25.0 | 6 | 20.0 | ||||
| 26.0 | 6 | 20.0 | 2 | 6.7 | ||
| 27.0 | 4 | 13.3 | 1 | 3.3 | ||
| 28.0 | 8 | 26.7 | ||||
| 29.0 | 4 | 13.3 | ||||
| 30.0 | 8 | 26.7 | ||||
| Total | 30 | 100.0 | 30 | 100.0 | 30 | 100.0 |
| Mean | 28.13 | 23.73 | 19.83 | |||
| SD | 1.48 | 1.44 | 0.79 | |||
| VI. | Mild severity | Mild severity | Minimal severity | |||
Table 2.
Patients’ wound status based on BWAT in the experimental group.
| BWAT score | Day 1 Hemostasis phase | Day 2 Inflammatory phase | Day 3 Proliferative phase | |||
|---|---|---|---|---|---|---|
| F | % | F | % | F | % | |
| 15.0 | 11 | 36.7 | ||||
| 16.0 | 13 | 43.3 | ||||
| 17.0 | 6 | 20.0 | ||||
| 18.0 | ||||||
| 19.0 | 5 | 16.7 | ||||
| 20.0 | 4 | 13.3 | ||||
| 21.0 | 2 | 6.7 | ||||
| 21.5 | 1 | 3.3 | ||||
| 22.0 | 11 | 36.7 | ||||
| 22.5 | 1 | 3.3 | ||||
| 23.0 | 4 | 13.3 | ||||
| 23.5 | ||||||
| 24 | 1 | 3.3 | ||||
| 24.5 | 1 | 3.3 | ||||
| 25.0 | ||||||
| 26.0 | ||||||
| 27.0 | 2 | 6.7 | ||||
| 28.0 | 16 | 53.3 | ||||
| 29.0 | 7 | 23.3 | ||||
| 30.0 | 5 | 16.7 | ||||
| Total | 30 | 100.0 | 30 | 100.0 | 30 | 100.0 |
| Mean | 28.50 | 21.45 | 15.83 | |||
| S.D. | 0.86 | 1.54 | 0.75 | |||
| VI | Mild severity | Mild severity | Minimal severity | |||
Table 3.
The day-to-day comparison of patients’ wound status after the application of usual care and operating room bundle of care.
Table 4.
Differences in patients’ wound status between control and experimental groups after application of the operating room bundle of care and usual care per day of evaluation.
| Day of evaluation | Mean | SD | Mann–Whitney | P-value | Interpretation |
|---|---|---|---|---|---|
| Day 1 Hemostasis phase | 390 | P = 0.355> 0.05 | Not significant | ||
| Control | 28.13 | 1.48 | |||
| Experimental | 28.5 | 0.86 | |||
| Day 2 Inflammatory phase | 129.5 | P = 0.000< 0.05 | Significant | ||
| Control | 23.73 | 1.44 | |||
| Experimental | 21.45 | 1.54 | |||
| Day 3 Proliferative phase | 0 | P = 0.000< 0.05 | Significant | ||
| Control | 19.83 | 0.79 | |||
| Experimental | 15.83 | 0.75 |